Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Book a demo for a pilot project
Shanghai Runshi Pharmaceutical Technology Co., Ltd., commonly referred to as Runshi Pharma, is a leading player in the pharmaceutical industry, headquartered in Shanghai, China. Established in 2010, the company has rapidly expanded its operations across major regions in Asia and beyond, focusing on innovative drug development and advanced pharmaceutical technologies.
Runshi Pharma specialises in the research, development, and manufacturing of high-quality active pharmaceutical ingredients (APIs) and finished dosage forms. Their commitment to quality and innovation sets them apart in a competitive market, with a strong emphasis on compliance with international regulatory standards.
With a robust portfolio of products and a reputation for excellence, Runshi Pharma has achieved significant milestones, including partnerships with global pharmaceutical companies and successful product launches. Their dedication to advancing healthcare solutions positions them as a trusted name in the pharmaceutical landscape.
No reported emissions data is available for Shanghai Runshi Pharmaceutical Technology Co., Ltd yet.
Shanghai Runshi Pharmaceutical Technology Co., Ltd, headquartered in CN, currently does not have available carbon emissions data for the most recent year. As a current subsidiary of CSPC Pharmaceutical Group Limited, any emissions data or climate commitments would be inherited from this parent organisation. However, specific emissions figures, reduction targets, or climate pledges have not been disclosed.
The company has not outlined any specific reduction initiatives or commitments, such as Science-Based Targets (SBTi) or other industry-standard climate pledges. This lack of data suggests that Shanghai Runshi Pharmaceutical Technology Co., Ltd may still be in the early stages of developing its climate strategy or reporting framework.
In the context of the pharmaceutical industry, companies are increasingly focusing on sustainability and carbon reduction to align with global climate goals. As such, it is essential for Shanghai Runshi Pharmaceutical Technology Co., Ltd to establish clear emissions targets and reduction strategies to enhance its environmental performance and meet stakeholder expectations.
No climate goals have been disclosed for Shanghai Runshi Pharmaceutical Technology Co., Ltd yet.
No scope 3 category breakdown has been disclosed yet.


No peer comparison is available for Shanghai Runshi Pharmaceutical Technology Co., Ltd yet.
PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more